Clinical trial
Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in…
NCT00305331 · University Health Network, Toronto, Other · Terminated
Key facts
| NCT number | NCT00305331 |
|---|---|
| Title | Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease |
| Official title | Phase II Clinical Trial of Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease, Peripheral Edema |
| Intervention type | Drug |
| Interventions | Domperidone (drug) |
| Enrollment | 25 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Mar 21, 2006 |
| Last update posted | Jul 30, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: